Elsevier

Vaccine

Volume 12, Issue 5, 1994, Pages 387-400
Vaccine

Review
New strategies for using mucosal vaccination to achieve more effective immunization

https://doi.org/10.1016/0264-410X(94)90112-0Get rights and content

Abstract

Future progress in vaccination will be significantly advanced by application of emerging technologies for immunization of mucosal surfaces. It should now be possible to maximize the antigenicity of many vaccines and facilitate their interaction with appropriate lymphoid tissues to induce protective cellular and humoral responses. Mucosal vaccines requiring no more than two doses are achievable with current technologies. Living vaccines have been among the most promising candidates for mucosal vaccination, but with few exceptions their promise is still to be realized. Development of new microencapsulated delivery systems and adjuvants has made non-living vaccines reasonable options for mucosal immunization. To be practical, such vaccines should be developed as combined agent vaccines, possibly deliverable by multiple mucosal routes. Although strategies to be used for specific mucosal vaccines will depend upon a number of factors pertinent to the disease agent, in concept an adjuvant administered with inactivated but maximally antigenic pathogens or their recombinant adhesive subcomponents could prove to be among the more practical mucosal vaccine options for use globally.

References (149)

  • J.C. Arroyo et al.

    Influenza A/Philippines/2/82 outbreak in a nursing home: limitation of influenza vaccination in the aged

    Am. J. Infect. Control

    (1984)
  • H.C. Whittle et al.

    Immunization of 4–6-month-old Gambian infants with Edmonston-Zagreb measles vaccine

    Lancet

    (1984)
  • F.L. Graham et al.

    Adenovirus-based expression vectors and recombinant vaccines

  • R.J. Whitley et al.

    Herpes simplex vaccines

  • I.E. Haffejee

    The status of rotavirus vaccines in 1990

    J. Infect.

    (1991)
  • A.Mcl. Mowat et al.

    ISCOMS — a novel strategy from mucosal immunization?

    Immunol. Today

    (1991)
  • J.J. Treanor et al.

    Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

    Ann. Intern. Med.

    (1992)

  • Editorial. Typhoid vaccination: Weighing the options

    Lancet

    (1992)
  • H. Faden et al.

    Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses

    J. Infect. Dis.

    (1990)

  • American Academy of Pediatrics

  • K. Redhead et al.

    Vaccines against pertussis

    Curr. Opin. Infect. Dis.

    (1990)
  • K.-C. Bergmann et al.

    Stimulation of secretory antibody following oral administration of antigen

    Rev. Infect. Dis.

    (1988)
  • M.R. Szewczuk et al.

    Lack of age-associated immune dysfunction in mucosal-associated lymph nodes

    J. Immun.

    (1981)
  • M. Garg et al.

    Immune responses of systemic and mucosal lymphoid organs to pnu-immune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant

    Infect. Immun.

    (1992)
  • R. Weiss

    Measles battle loses potent weapon

    Science

    (1992)
  • E.D. Shapiro

    Infections caused by Hemophilus influenzae type B. The beginning of the end?

    JAMA

    (1993)
  • P. Brandtzaeg

    Overview of the mucosal immune system

    Curr. Top. Microbiol. Immunol.

    (1989)
  • D. Hone et al.

    Vaccination against enteric bacterial diseases

    Rev. Infect. Dis.

    (1989)
  • J. Mestecky et al.

    Oral immunization: past and present

    Curr. Top. Microbiol. Immunol.

    (1989)
  • C.F. Kuper et al.

    The role of nasopharyngeal lymphoid tissue

    Immunol. Today

    (1992)
  • McGhee, J.R. and Kiyono, H. Effective mucosal immunity: Current concepts for vaccine delivery and immune response...
  • L. Winner et al.

    New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection

    Infect. Immun.

    (1991)
  • P. Michetti et al.

    Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium

    Infect. Immun.

    (1992)
  • M.J. Walker et al.

    Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aro A, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit

    Infect. Immun.

    (1992)
  • M.R. McDermott et al.

    Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2

    J. Gen. Virol.

    (1990)
  • T. Lehner et al.

    A primate model of immunization inducing mucosal and systemic immunity to SIV antigen

  • P. Wernet et al.

    Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine

    J. Infect. Dis.

    (1971)
  • J. Kaur et al.

    Immunity to cholera: antibody response in the lower ileum of the rabbit

    J. Infect. Dis.

    (1971)
  • U. Dahlgren et al.

    The localization of the antibody response in milk or bile depends on the nature of the antigen

    J. Immunol.

    (1987)
  • U. Dahlgren et al.

    Induction of the mucosal immune response

    Curr. Top. Microbiol. Immunol.

    (1989)
  • D. Cohen et al.

    Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic shigella infections

    J. Clin. Microbiol.

    (1989)
  • J.B. Robbins et al.

    Hypothesis for vaccine development: Protective immunity to enteric diseases caused by non-typhoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides

    Clin. Infect. Dis.

    (1992)
  • R.K. Gupta et al.

    Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae of 01 serotype Inaba bound to cholera toxin

    Infect. Immun.

    (1992)
  • S.B. Formal et al.

    Failure of parenteral vaccines to protect monkeys against experimental shigellosis

  • M.E. Conner et al.

    Rotavirus vaccine administered parenterally induces protective immunity

    J. Virol.

    (1993)
  • R.L. Owen et al.

    M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration

    J. Infect. Dis.

    (1986)
  • R.L. Owen et al.

    Bacterial characteristics and follicle surface structure: their roles in Peyer's patch uptake and transport of Vibrio cholerae

  • R.L. Owen et al.

    Effects of bacterial inactivation methods, toxin production and oral immunization on uptake of Vibrio cholerae by Peyer's patch lymphoid follicles

  • J.S. Wassef et al.

    Role of M cells in initial antigen uptake and in ulcer formation in the intestinal loop model of shigellosis

    Infect. Immun.

    (1989)
  • H.J. de Aizpurua et al.

    Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

    J. Exp. Med.

    (1988)

    • Cited by (0)

    1

    Present address: MicroCarb, Inc., 300 Professional Drive, Gaithersburg, MD 20879, USA

    View full text
    Copyright © 1994 Published by Elsevier Ltd.